Harry M Jansen Jr Kraemer

Director Harry M. Jansen Jr. Kraemer purchases over 36,600 shares of OPCH in open market amid significant stock decline.

Harry M. Jansen Jr. Kraemer, a director at Option Care Health, deployed nearly $784,000 to purchase over 36,600 shares at market prices while the stock has retreated substantially from its recent highs and has fallen sharply over the past three months. What makes this trade noteworthy is the timing: Kraemer is buying aggressively into weakness rather than during periods of price strength, which is the classic hallmark of insider conviction that the market has overreacted to recent headwinds. The company remains profitable with growing revenue and is trading at a reasonable valuation multiple, suggesting the fundamentals have not deteriorated despite the stock's recent decline. This director's willingness to increase his stake significantly at these depressed levels—without the vesting or exercise complications that can cloud many insider trades—suggests he views the pullback as a genuine opportunity rather than a sign of deeper trouble ahead.

Director Kraemer buys 38,000 OPCH shares at $25.98; holdings increase 10.1% to 413,390 shares.

Director Kraemer purchased 38,000 shares at $25.98 on 2025-11-03, expanding his position by 10.1% to 413,390 shares total, representing a $987,392.00 commitment. At the current price of $27.03, the stock trades -23.2% below its 52-week high of $35.20. His prior four trades at Option Care Health show a mixed timing record: one measurable 90-day outcome was well-timed (the 2024-11-08 buy, which returned +36.8%), while three others showed negative 90-day returns (-8.0%, -18.5%, and one not yet measurable). The company shows solid fundamentals with $1.4B quarterly revenue, $51.8M net income, and annual growth of +16.2%, though the current P/E of 20.48 reflects elevated valuations. The 10.1% increase in holdings is material and suggests continued engagement with the stock at levels below historical highs.

Director Kraemer buys 36,000 OPCH shares at $27.15; stock -20.9% from 52-week high; 3 other insiders also bought within 14 days.

Director Harry M Jansen Jr Kraemer purchased 36,000 shares of Option Care Health at $27.15 on 2025-08-20, increasing his holdings by 10.6% to 375,390 shares, representing a $977.3K investment. The buy occurs with the stock trading -20.9% from its 52-week high of $35.20 and down -6.5% over the past 30 days, while the company shows solid fundamentals with $1.4B in quarterly revenue, +16.2% annual growth, and $50.5M net income. His prior OPCH transaction history is mixed: one well-timed buy on 2024-11-08 that returned +36.8% at 90 days, but two poorly-timed buys in 2024 and 2023 that underperformed or declined. A cluster of 3 other insiders also buying within the past 14 days adds a multi-director buy signal, though the insider's own track record at this ticker shows only 33% alignment with strong 90-day returns.

Director Harry M. Kraemer Jr. buys 43,000 shares of OPCH at $22.54; stock down 35.4% from 52-week high.

Director Harry M. Kraemer Jr. purchased 43,000 shares (43.0K shares) at $22.54 on 2024-11-08, increasing his holdings to 326,334 shares (326.3K shares), a 15.2% increase from pre-transaction holdings of 283,334 shares (283.3K shares). The purchase occurs against a backdrop of significant recent price weakness: the current price of $22.18 is 35.4% below the 52-week high of $34.31 and down 27.5% over the past 30 days. At the same-ticker level, Kraemer's prior two buys at OPCH (on 2024-02-26 and 2023-08-11) produced 90-day returns of -8.0% and -18.5% respectively, showing a pattern where post-purchase price declines have followed. His cross-ticker track record shows 0% 90-day win rate across 2 prior buys with an average 90-day return of -13.2%, indicating a historical tendency to purchase near or into sustained weakness rather than near inflection points.